跳至主要内容
临床试验/NCT06479772
NCT06479772已完成不适用

Evaluation of the Potential Impact of an Artificial Intelligence Solution in Second Reading of Organized Screening.

GCS Ramsay Santé pour l'Enseignement et la Recherche1 个研究点 分布在 1 个国家目标入组 55,589 人开始时间: 2023年10月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
55,589
试验地点
1
主要终点
Percentage of real negatives

研究概览

简要总结

Based on data from a series of patients who underwent screening mammography with a "normal" or "benign" first-reading result. The main objective of the study is to evaluate the possibilities of subtracting from the second reading of breast cancer screening a population of examinations for which the risk of discovering cancer is close to zero, using an AI system (here the MammoScreen™ system).

详细描述

This is a retrospective multicenter study of mammography imaging data contained in the PACS (Picture Archiving and Communication System) of six radiology centers located in the Rhône, Puy de dôme, Cantal and Haute-Loire départements.

In order to be able to collect two-year follow-up data, the files analyzed will concern all women who received a screening mammogram during the years 2015, 2016, 2017, 2018 and 2019. More recent mammograms will be excluded.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
50 Years 至 74 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged 50 to 74 participating in the organized screening campaign.
  • Having had a screening mammogram with a final L1 result of "normal" (ACR 1/ BI-RADS 1) or "benign" (ACR 2/ BI-RADS 2).
  • For which a second reading interpretation is available
  • Screening mammograms performed during the years 2015 to2019 (In order to have follow-up data (subsequent mammogram or information on the person's future)

排除标准

  • Mammography not performed as part of organized screening

结局指标

主要结局

Percentage of real negatives

时间窗: Week 8

Percentage of cases negatived by MammoScreen (considered benign by the system), and for which no cancer was detected at the end of the L2 (according to the different risk levels of the MammoScreen software - score from 1 to 10). We distinguish two sub-populations: L2- and L2+ with BDD- (in addition to L2-).

次要结局

  • Percentage of real positives(Week 8)
  • Percentage of false negatives(Week 8)

研究者

发起方
GCS Ramsay Santé pour l'Enseignement et la Recherche
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验